By: Paul Purlain 11 October 2010 The U.S. Department of Health and Human Services’ Biomedical Advanced Research Development Authority has announced a new contract worth $57 million to help safeguard the United States in the case of a pandemic influenza outbreak. The contract with French pharmaceutical company Sanofi Pasteur is an extension of an existing […]
SLU to study best flu vaccine dose for young children
Posted on St. Louis Public Radio News 11 October 2010 Saint Louis University is participating in a study to determine the best flu vaccine dose for young children. Currently, children between 6 and 35 months of age receive a dose of 0.25 ml – half the dose given to older children and adults. But SLU […]
The 2009 H1N1 Pandemic Influenza Virus: What Next?
By: David M. Morgan, et al; National Institute of Allergy and Infectious Diseases 28 September 2010 Abstract: History suggests that the 2009 pandemic H1N1 influenza virus faces extinction unless it mutates to avoid already high global population immunity. The immune escape mechanisms potentially at its disposal include antigenic drift, antigenic shift via genetic reassortment, and […]
Flu Research to Examine Pregnancy Vaccination/Benefit to Infant
Posted in the Daily News Journal 27 September 2010 Nashville — The Vanderbilt Vaccine Research Program is looking for dozens of pregnant women to participate in research on the use of flu vaccine. The study will evaluate the immune responses to the influenza vaccine in both mother and infant. Vanderbilt is one of several sites […]
Thousands of U.S.A. Pregnant Women Miscarry after H1N1 Vaccine
By: Christina England, American Chronicle 27 September 2010 A new report by the National Coalition of Organized Women (NCOW), states, that as many as 3,587 cases, may of either miscarried or had a stillbirth after receiving the H1N1 vaccine. In an exceptionally strong and well executed report, written on the Child Health Safety Website entitled […]
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 43
- Next Page »